Szapary PO - Search Results

1

A randomized trial of a low-carbohydrate diet for obesity.

Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman JS, Klein S. Foster GD, et al. Among authors: szapary po. N Engl J Med. 2003 May 22;348(21):2082-90. doi: 10.1056/NEJMoa022207. N Engl J Med. 2003. PMID: 12761365 Free article. Clinical Trial.

2

A randomized trial of the effects of an almond-enriched, hypocaloric diet in the treatment of obesity.

Foster GD, Shantz KL, Vander Veur SS, Oliver TL, Lent MR, Virus A, Szapary PO, Rader DJ, Zemel BS, Gilden-Tsai A. Foster GD, et al. Among authors: szapary po. Am J Clin Nutr. 2012 Aug;96(2):249-54. doi: 10.3945/ajcn.112.037895. Epub 2012 Jun 27. Am J Clin Nutr. 2012. PMID: 22743313 Free PMC article. Clinical Trial.

3

Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial.

Szapary PO, Wolfe ML, Bloedon LT, Cucchiara AJ, DerMarderosian AH, Cirigliano MD, Rader DJ. Szapary PO, et al. JAMA. 2003 Aug 13;290(6):765-72. doi: 10.1001/jama.290.6.765. JAMA. 2003. PMID: 12915429 Clinical Trial.

4

Physical activity and its effects on lipids.

Szapary PO, Bloedon LT, Foster GD. Szapary PO, et al. Curr Cardiol Rep. 2003 Nov;5(6):488-92. doi: 10.1007/s11886-003-0112-2. Curr Cardiol Rep. 2003. PMID: 14558992 Review.

5

The triglyceride-high-density lipoprotein axis: an important target of therapy?

Szapary PO, Rader DJ. Szapary PO, et al. Am Heart J. 2004 Aug;148(2):211-21. doi: 10.1016/j.ahj.2004.03.037. Am Heart J. 2004. PMID: 15308990 Review.

6

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.

Cuchel M, Bloedon LT, Szapary PO, Kolansky DM, Wolfe ML, Sarkis A, Millar JS, Ikewaki K, Siegelman ES, Gregg RE, Rader DJ. Cuchel M, et al. Among authors: szapary po. N Engl J Med. 2007 Jan 11;356(2):148-56. doi: 10.1056/NEJMoa061189. N Engl J Med. 2007. PMID: 17215532 Free article. Clinical Trial.

7

Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.

Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, Szapary PO. Bloedon LT, et al. Among authors: szapary po. J Am Coll Nutr. 2008 Feb;27(1):65-74. doi: 10.1080/07315724.2008.10719676. J Am Coll Nutr. 2008. PMID: 18460483 Clinical Trial.

8

Pharmacological management of high triglycerides and low high-density lipoprotein cholesterol.

Szapary PO, Rader DJ. Szapary PO, et al. Curr Opin Pharmacol. 2001 Apr;1(2):113-20. doi: 10.1016/s1471-4892(01)00028-5. Curr Opin Pharmacol. 2001. PMID: 11714084 Review.

9

Management of selected lipid abnormalities: hypertriglyceridemia, isolated low HDL-cholesterol, lipoprotein(a), and lipid abnormalities in renal diseases and following solid organ transplantation.

Rosas S, Szapary P, Rader DJ. Rosas S, et al. Cardiol Clin. 2003 Aug;21(3):377-92. doi: 10.1016/s0733-8651(03)00075-4. Cardiol Clin. 2003. PMID: 14621452 Review.

10

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome.

Szapary PO, Bloedon LT, Samaha FF, Duffy D, Wolfe ML, Soffer D, Reilly MP, Chittams J, Rader DJ. Szapary PO, et al. Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8. doi: 10.1161/01.ATV.0000195790.24531.4f. Epub 2005 Nov 10. Arterioscler Thromb Vasc Biol. 2006. PMID: 16284192 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page